Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
BMC Infectious Diseases|April 6, 2023
Herpesvirus immunology in solid organ transplant recipients - liver transplant study (HISTORY): a retrospective and prospective observational cohort studyMoises Alberto Suarez-Zdunek, Sunil Kumar Saini, Christian Ross Pedersen, et al.
Cancer Research|February 8, 2012
Dissection of T-cell antigen specificity in human melanomaRikke Sick Andersen, Charlotte Albæk Thrue, Niels Junker, et al.
Science Advances|April 12, 2024
Simultaneous analysis of pMHC binding and reactivity unveils virus-specific CD8 T cell immunity to a concise epitope setNikolaj Pagh Kristensen, Edoardo Dionisio, Amalie Kai Bentzen, et al.
Frontiers in Immunology|January 27, 2023
Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patientsSusana Patricia Amaya Hernandez, Ditte Stampe Hersby, Kamilla Kjærgaard Munk, et al.
Nature Protocols|April 14, 2012
Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimersRikke Sick Andersen, Pia Kvistborg, Thomas Mørch Frøsig, et al.
Oncoimmunology|November 20, 2019
T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patientsNadia Viborg, Sofie Ramskov, Rikke Sick Andersen, et al.
NPJ Vaccines|May 27, 2023
DNA based neoepitope vaccination induces tumor control in syngeneic mouse modelsNadia Viborg, Michail Angelos Pavlidis, Marina Barrio-Calvo, et al.
Plos One|September 10, 2009
The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenaseRikke Baek Sørensen, Linda Berge-Hansen, Niels Junker, et al.
Cancer Immunology, Immunotherapy : CII|July 4, 2021
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trialStaffan Holmberg-Thydén, Inge Høgh Dufva, Anne Ortved Gang, et al.
Frontiers in Immunology|August 2, 2024
Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytesThomas Morgan Hulen, Christina Friese, Nikolaj Pagh Kristensen, et al.
Pageof 10